Charlene Kay
- Co-authors
- Arran TurnbullSimon P. LangdonDana FaratianDavid J. HarrisonJames MeehanCarlos Martínez-PérezMark GrayPeter Mullen
- Topics
- HER2/EGFR in Cancer Research (16 papers)Breast Cancer Treatment Studies (10 papers)Advanced Breast Cancer Therapies (6 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Charlene Kay
31 papers receiving 944 citations
Peers
Comparison fields: 5 of 97
- Oncology 443
- Molecular Biology 433
- Cancer Research 366
- Pulmonary and Respiratory Medicine 193
- Genetics 158
Countries citing papers authored by Charlene Kay
This map shows the geographic impact of Charlene Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlene Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlene Kay more than expected).
Fields of papers citing papers by Charlene Kay
This network shows the impact of papers produced by Charlene Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlene Kay. The network helps show where Charlene Kay may publish in the future.
Co-authorship network of co-authors of Charlene Kay
This figure shows the co-authorship network connecting the top 25 collaborators of Charlene Kay. A scholar is included among the top collaborators of Charlene Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlene Kay. Charlene Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 11 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 78 | |
| 7 | 42 | |
| 8 | 22 | |
| 9 | 4 | |
| 10 | 25 | |
| 11 | 19 | |
| 12 | 38 | |
| 13 | Best Practices For Risk-Based Forecasts Of Land Volatility For Corridor Management And Sustainable Communities | 4 |
| 14 | 41 | |
| 15 | 44 | |
| 16 | 142 | |
| 17 | 47 | |
| 18 | 126 | |
| 19 | 44 | |
| 20 | 5 |
About Charlene Kay
Charlene Kay is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 954 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (10 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Cancer Research (366 citations), Oncology (443 citations) and Molecular Biology (433 citations). Charlene Kay has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Arran Turnbull, Simon P. Langdon, Dana Faratian, David J. Harrison, James Meehan, Carlos Martínez-Pérez, Mark Gray, Peter Mullen, Andrew H. Sims and In Hwa Um. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.